Regeneron Pharmaceuticals Reports - Industry Research

Reports Featuring Regeneron Pharmaceuticals

Carbonated Beverages Market Major Players

Atopic Dermatitis Market

The Atopic Dermatitis Market size is estimated at USD 10.06 billion in 2024, and is expected to reach USD 14.23 billion by 2029, growing at a CAGR of 7.18% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Macular Degeneration Treatment Market

The Macular Degeneration Treatment Market size is estimated at USD 15.47 billion in 2024, and is expected to reach USD 23.29 billion by 2029, growing at a CAGR of 8.51% during the forecast period (2024-2029).

Carbonated Beverages Market Major Players

Retinal Biologics Market

The retinal biologics market studied is anticipated to record a CAGR of nearly 6.8% during the forecast period.

Carbonated Beverages Market Major Players

Global Gout Therapeutics Market

The Gout Therapeutics market is anticipated to grow with a CAGR of 15.5%, over the forecast period (2022 - 2027).

Carbonated Beverages Market Major Players

Global Diabetic Retinopathy Market

The Diabetic Retinopathy Market is poised to grow at a CAGR of 11.5% during the study period, 2022-2027.

Carbonated Beverages Market Major Players

Immune Checkpoint Inhibitors Market

The immune checkpoint inhibitors market is anticipated to register a CAGR of 18% during the forecast period.

Carbonated Beverages Market Major Players

Global Atherosclerosis Drugs Market

The Atherosclerosis Drugs Market is projected to register a CAGR of 2.2% during the forecast period (2022-2027).

Carbonated Beverages Market Major Players

Pediatric Respiratory Disease Therapeutics Market

The pediatric respiratory disease therapeutics market is expected to register a CAGR of 5.6% over the forecast period.

Carbonated Beverages Market Major Players

Proliferative Diabetic Retinopathy Market

The Proliferative Diabetic Retinopathy Market is expected to register a CAGR of 9.4% during the forecast period.

Carbonated Beverages Market Major Players

Posterior Segment Eye Disorders Market

The Posterior Segment Eye Disorders Market size is estimated at USD 32.12 billion in 2024, and is expected to reach USD 41.82 billion by 2029, growing at a CAGR of 5.42% during the forecast period (2024-2029).

Industries Regeneron Pharmaceuticals Operates Within:

Regeneron Pharmaceuticals Competitors